Pithmark is an independent resource focused on clear distinctions around iboga plant parts, compounds, and risks. Our work exists to help readers separate confident claims from uncertainty and to make editorial clarity available without promoting products or treatments.
We organize practical, tissue-specific material, editorial explainers, and safety notes in a compact, browsable way so people can find distinctions quickly and read deeper where needed. For example, our Services page explains the kinds of editorial reviews we offer for product claims and content audits; you can see that structure on our services overview when evaluating scope.
We prioritize primary literature, regulatory guidance, and publicly accessible registries when assessing product and tissue claims. For general background on how standards bodies collate evidence, sources such as the National Institutes of Health provide transparent overviews; for instance, NIH resources explain how evidence reviews are structured at the agency level (National Institutes of Health).
Content emphasizes which plant tissue or preparation a claim targets and whether evidence supports that specific tissue. Our site navigation points to specialized pages like Fruit vs Root that hold focused comparisons rather than mixing answers in a single page.
We flag safety uncertainty and avoid therapeutic claims. For authoritative context on risk communication, we reference public health guidance such as documents hosted by government health agencies (Centers for Disease Control and Prevention).
We publish explainers, comparisons, and assessments that separate plant tissues (fruit, root bark, extracts), summarize alkaloid-level uncertainty, and describe common product claims and their evidence limits. Our pages link to supporting materials and to service descriptions when a reader wants a deeper editorial review; for instance, readers may consult industry-oriented resources like the European treatment center directories when seeking context about service claims (directory of ibogaine treatment centers in Europe).
We do not provide clinical advice, dosing guidance, or endorsements of therapies; our role is informational and clarifying.
When we state a firm claim, it is grounded in at least one primary source or an authoritative registry; for basic definitions we also consult established reference works like Wikipedia's pharmacology overview to align terminology with widely used descriptors.
If an assertion rests primarily on vendor materials or single, unpublished reports, we label it as provisional and describe the gaps readers should watch for.
We cite sources and label what we cannot verify.
We do not accept editorial control from vendors or clinics.
We favor corroborated, tissue-specific evidence over broad product assertions.
For editorial services and content reviews that tailor depth and citation style, our overview on services for publishers and product reviewers describes deliverables, turnaround, and limits. We also link readers back to the indexed front page when they need a quick site orientation: the site index is available from the main navigation or via the visible site wordmark at the top of every page (site index and front page).
Pithmark is an independent resource on iboga fruit, root bark, alkaloids, product claims, and safety uncertainty. We are not a clinic, medical provider, or licensed treatment center, and nothing on this site should be interpreted as medical or legal advice. If you are seeking care, please consult an authorized medical professional or an appropriate licensed service provider.
Our values—tissue-specific clarity, evidence before claims, harm awareness, plain language, and independence—guide what we publish and how we edit. For questions about editorial methodology or to request a content review, consult the contact page.